#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma stage II Immunodeficiency common variable Metastatic malignant melanoma Chondrosarcoma metastatic Cervix carcinoma recurrent Mixed-type liposarcoma Scedosporium infection Atypical haemolytic uraemic syndrome Advanced systemic mastocytosis Obesity Congenital disorder of glycosylation Endometrial adenocarcinoma SAPHO syndrome Congenital growth hormone deficiency Gastric cancer More trials…

    Learn about Rare Diseases

    Immunodeficiency congenital – Treatment Cystic fibrosis – Treatment Brain stem glioma – Life with Disease Metachromatic leukodystrophy – Trials in Disease Advanced systemic mastocytosis – Basic Information Antisynthetase syndrome – Life with Disease Marginal zone lymphoma refractory – Life with Disease Chondrosarcoma – Life with Disease Waldenstrom’s macroglobulinaemia – Treatment Short-bowel syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cart 19/22 T Cells Copper (64Cu) Chloride Remifentanil Meropenem Aflibercept Imetelstat Sodium Ulonivirine Lactic Acid Oxytocin COLESEVELAM HYDROCHLORIDE Leflunomide Nido-361 Ketoprofen Lysine Pivekimab Sunirine Nimodipine Eo2318 ILOPROST Plerixafor Selexipag AMODIAQUINE More therapies…

    Learn about Your Condition

    Metastases to biliary tract Abdominal wall pain Rheumatic disorder Coronary artery dissection Multiple system atrophy Choroidal neovascularisation Lipid metabolism disorder Chronic hepatitis C Hyperhidrosis Tympanic membrane hyperaemia Lymphangioma Richter's syndrome Pseudomonas infection Gestational diabetes Brain injury More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Camizestrant and Abemaciclib in Patients with ER‑positive HER2‑negative Metastatic Breast Cancer Who Show Rising ctDNA

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Camizestrant
    • Abemaciclib
    France

  • Patient‑chosen treatment vs routine surgery for adult uncomplicated acute appendicitis: trial of amoxicillin‑clavulanic acid versus appendectomy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Appendicitis
    Investigated Drugs:
    • Amoxicillin Sodium
    • Clavulanic Acid
    France

  • Effect of Stopping Long‑Term Azithromycin in Stable Non‑Cystic Fibrosis Bronchiectasis Patients: A Randomized Controlled Trial

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cystic fibrosis
    Investigated Drugs:
    • Azithromycin
    France

  • Study of Cemiplimab, Platinum and Gemcitabine in Treatment‑Naïve Patients with Advanced Squamous Non‑Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of lung
    Investigated Drugs:
    • Cemiplimab
    Italy

  • A Phase 2 Study of Methylenedioxymethamphetamine‑Assisted Therapy in Young Adults (18‑25) with Chronic Treatment‑Resistant Major Depressive Disorder

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Major depression
    Norway

  • Effect of dry extract from Psilocybe cubensis (15‑25:1), extraction solvent methanol, with psychotherapy versus basic support on depressive symptoms in adults with depression

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    Denmark
Previous Page
1 … 683 684 685 686 687 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!